Lexicon Pharmaceuticals, Inc. (LXRX)
2.23
-0.10
(-4.29%)
USD |
NASDAQ |
May 15, 16:00
2.21
-0.02
(-0.90%)
After-Hours: 20:00
Lexicon Pharmaceuticals EPS Diluted (Quarterly) : -0.0026 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Liquidia Corp. | 0.5228 |
| Novo Nordisk A/S | 1.709 |
| Emmaus Life Sciences, Inc. | -0.0475 |
| Nutriband, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.043M |
| Revenue (Quarterly) | 21.10M |
| Total Expenses (Quarterly) | 22.14M |
| Enterprise Value | 877.61M |
| Gross Profit Margin (Quarterly) | 98.97% |
| Profit Margin (Quarterly) | -4.94% |
| Earnings Yield | -3.21% |
| Normalized Earnings Yield | -3.206 |